So you want to be a regulatory affairs professional - here's how to get started:

Joan Kwong Credit: Courtesy of Pat Dougherty" />Joan Kwong Credit: Courtesy of Pat Dougherty The academic two-step. For a PhD coming straight out of academia, the switch to regulatory affairs can be tough, but not impossible. "It's very doable," but it takes two transitions, David Jensen says. You'll have to start by moving from the academic bench to the industry bench, keeping in mind that the company is interested in hiring you for the research experience you have right now. O

Written byKelly Rae Chi
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The academic two-step. For a PhD coming straight out of academia, the switch to regulatory affairs can be tough, but not impossible. "It's very doable," but it takes two transitions, David Jensen says. You'll have to start by moving from the academic bench to the industry bench, keeping in mind that the company is interested in hiring you for the research experience you have right now. Once you get your foot in the door, start letting people know right away that you're interested in regulatory affairs down the road, he says. Network within your company and take training courses. A transition could take less than two years. "Take those transitions one at a time and be patient," Jensen says.

You'll be fighting against the bottom line, so have thick skin. As a regulatory professional, you'll be dealing with high-level executives who don't have science backgrounds, and who might not understand ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies